ImmunityBio, Inc.IBRXNASDAQ
Loading
Enterprise value to EBITDA ratio
Latest
-11.68
↑ 10% vs avg
Percentile
P58
Within normal range
Streak
2 yr
Consecutive declineContracting
Average
-12.98
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| 2025 | -11.68 | -43.9% |
| 2024 | -8.11 | -28.8% |
| 2023 | -6.30 | +16.3% |
| 2022 | -7.52 | +14.8% |
| 2021 | -8.83 | +66.3% |
| 2020 | -26.19 | -2.6% |
| 2019 | -25.53 | -503.2% |
| 2018 | -4.23 | +72.6% |
| 2017 | -15.46 | +3.2% |
| 2016 | -15.97 | - |